Welcome to our dedicated page for Truleum news (Ticker: TRLM), a resource for investors and traders seeking the latest updates and insights on Truleum stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Truleum's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Truleum's position in the market.
Truleum has provided an update on its auditor and S-1 registration statement status. On May 3, 2024, the SEC barred BF Borgers CPA PC from auditing, impacting Truleum's Q1 2024 financials and S-1 statement. In response, Truleum terminated Borgers and hired Barton CPA to re-audit its financials for the past two years. The company will amend its S-1 registration post re-audit, aiming for transparency and compliance. Truleum is also focused on obtaining an effective registration statement and uplisting to the NYSE American Stock Exchange.
Summary not available.